Position in ABCL
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$730
+$523 QoQ
Shares Held
93
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#148
of 150 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $7,168,968 across 46 Biotechnology names. ABCL ranks #38 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMRN |
Biomarin Pharmaceutical Inc
|
104,492 | $5,979,032 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
13,352 | $520,193 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
665 | $330,325 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,403 | $76,337 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
73 | $45,518 | |
| 6 | INCY |
Incyte Corp
|
315 | $35,708 | |
| 7 | RPRX |
Royalty Pharma plc
|
427 | $23,941 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
55 | $13,253 |
All Filings in ABCL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $730 | 93 | Shares | Sole | 2026-08-06 | |
| 2025-03-31 | $207 | 93 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $272 | 93 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $241 | 93 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $275 | 93 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $421 | 93 | Shares | Sole | 2024-05-13 | |
| No filing history on record for this holder in this stock. | ||||||